Medtronic Starts International Study Of CoreValve(R) Transcatheter Aortic Valve System

March 14th, 2010 | Category: Cardiology

Moving to expand the evidence base for the future of structural heart disease therapy, Medtronic, Inc. (NYSE: MDT), announced the start of the first of several

new initiatives in a robust international clinical program for its CoreValve transcatheter aortic valve system, a minimally-invasive alternative to open-heart surgery for aortic valve replacement…

Share and Enjoy: These icons link to social bookmarking sites where readers can share and discover new web pages.